pyrazines has been researched along with lde225 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amodio, N; Anderson, KC; Azab, AK; Blotta, S; Calimeri, T; Foresta, U; Jakubikova, J; Mitsiades, CS; Molica, S; Morabito, F; Munshi, NC; Neri, A; Roccaro, AM; Rossi, M; Tagliaferri, P; Tassone, P; Todoerti, K | 1 |
| Amm, HM; Burke, MR; Dobbin, ZC; Jeong, DH; Katre, AA; Landen, CN; Steg, AD | 1 |
2 other study(ies) available for pyrazines and lde225
| Article | Year |
|---|---|
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Mice; Mice, SCID; Multiple Myeloma; Patched Receptors; Patched-1 Receptor; Plasma Cells; Pyrazines; Pyridines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Smoothened Receptor; Syndecan-1 | 2012 |
Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Boronic Acids; Bortezomib; Bridged-Ring Compounds; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Female; Hedgehog Proteins; Humans; Ovarian Neoplasms; Proteasome Inhibitors; Pyrazines; Pyridines; Signal Transduction; Taxoids | 2014 |